Vertex Pharmaceuticals (VRTX) Total Debt (2009 - 2016)
Vertex Pharmaceuticals' quarterly Total Debt came in at $300.0 million in Q4 2016, up 1.64% year-on-year from $295.2 million in Q1 2016, and up 0.76% quarter-over-quarter from $297.8 million in Q3 2016.
Vertex Pharmaceuticals has reported Total Debt for 6 years, with the latest figure at $300.0 million in Q4 2016.
- For the quarter ending Q4 2016, Total Debt rose 1.64% year-over-year to $300.0 million; the trailing twelve-month figure through Dec 2016 stood at $300.0 million (up 1.64% YoY), and the FY2016 full-year result was $300.0 million, up 1.64% from the prior year.
- Total Debt for Q4 2016 stood at $300.0 million, up from $297.8 million in the prior quarter.
- The five-year high for Total Debt was $300.0 million in Q4 2016, with the low at $294.7 million in Q3 2014.
- Average Total Debt over 3 years is $295.9 million, with a median of $295.0 million recorded in 2015.
- Year-over-year, Total Debt rose 0.03% in 2015 and advanced 1.64% in 2016.
- Tracing VRTX's Total Debt over 3 years: stood at $294.8 million in 2014, then rose by 0.13% to $295.2 million in 2015, then advanced by 1.64% to $300.0 million in 2016.
- The last three Total Debt figures came in at $300.0 million (Q4 2016), $297.8 million (Q3 2016), and $296.5 million (Q2 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 300.00 Mn |
| Sep 30, 2016 | 297.75 Mn |
| Jun 30, 2016 | 296.50 Mn |
| Mar 31, 2016 | 295.82 Mn |
| Dec 31, 2015 | 295.16 Mn |
| Sep 30, 2015 | 294.83 Mn |
| Jun 30, 2015 | 294.81 Mn |
| Mar 31, 2015 | 294.79 Mn |
| Dec 31, 2014 | 294.78 Mn |
| Sep 30, 2014 | 294.74 Mn |
| Sep 30, 2011 | 98.42 Mn |
| Mar 31, 2011 | 92.10 Mn |
| Dec 31, 2010 | 77.80 Mn |
| Sep 30, 2010 | 45.28 Mn |
| Jun 30, 2010 | 163.66 Mn |
| Dec 31, 2009 | 143.38 Mn |